Business
Germany recommends against giving Oxford-AstraZeneca vaccine to over 65s – Sydney Morning Herald
The country’s vaccine committee says there is not enough trial data available for the age group. Australia says it trusts the TGA’s assessment.
The experts endorsed the vaccines rollout for people aged 18 to 64.
The European Unions drug regulator, the European Medicines Agency, will hand down its verdict on the vaccine on Friday.
Australia has rights to 53.8 million doses of the vaccine developed by AstraZeneca and the University of Oxford, representing the bulk of its initial portfolio.
The Australian Therapeutic Goods Administration has also been scrutinising AstraZenecas trial data ahead of an expected decision in February on whether…
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News22 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General16 hours agoAlbo and Dutton do battle for the Port of Darwin